Bio-Tech Pharmacal, Inc.   Report issue

For profit Phase 3
Founded: Fayetteville AR United States (1984)
Status: No NME R&D (1984)

Organization Overview

First Clinical Trial
2009
NCT00903344
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

vitamin d3 (3 trials)

Drugs in Other Trials (1)

multivitamins (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Avitaminosis (Phase 3)

Rickets (Phase 3)

Vitamin D Deficiency (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 2